|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,416.00 JPY | -0.12% |
|
+5.00% | +11.21% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-30 | Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,137B 7.14B 6.18B 5.79B 5.28B 9.94B 681B 10.11B 67.89B 26.6B 341B 26.8B 26.21B | P/E 2027 * |
15.9x | P/E 2028 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 936B 5.88B 5.09B 4.77B 4.35B 8.19B 561B 8.33B 55.92B 21.91B 281B 22.07B 21.59B | EV / Sales 2027 * |
2.06x | EV / Sales 2028 * | 2x |
| Free-Float |
80.98% | Yield 2027 * |
3.24% | Yield 2028 * | 3.21% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | -0.12% | ||
| 1 week | +5.00% | ||
| Current month | +1.34% | ||
| 1 month | +0.65% | ||
| 3 months | -2.54% | ||
| 6 months | -3.55% | ||
| Current year | +11.21% |
| 1 week | 2,296.5 |  | 2,430.5 |
| 1 month | 2,264.5 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | +5.00% | +40.26% | -12.95% | 7.14B | |
| +0.10% | +0.21% | +19.84% | +71.39% | 48.85B | |
| -2.47% | +3.77% | +55.63% | +121.20% | 41.43B | |
| +1.18% | +7.48% | +26.09% | +87.80% | 12.46B | |
| 0.00% | +0.29% | -3.85% | +18.40% | 12.39B | |
| +1.06% | -0.38% | +30.98% | +136.36% | 9.08B | |
| -0.77% | +6.85% | +23.83% | +39.14% | 7.53B | |
| +0.62% | +1.37% | +11.26% | +187.09% | 6.73B | |
| -1.22% | +4.46% | -25.04% | +29.64% | 5.88B | |
| +0.97% | +3.01% | +31.28% | +103.67% | 4.59B | |
| Average | -0.07% | +3.14% | +21.03% | +78.17% | 15.61B | |
| Weighted average by Cap. | -0.50% | +3.34% | +28.01% | +84.45% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 455B 2.85B 2.47B 2.32B 2.11B 3.98B 272B 4.04B 27.16B 10.64B 136B 10.72B 10.49B | 445B 2.79B 2.42B 2.26B 2.07B 3.89B 266B 3.95B 26.55B 10.4B 133B 10.48B 10.25B |
| Net income | 71.42B 448M 389M 364M 332M 625M 42.77B 635M 4.27B 1.67B 21.41B 1.68B 1.65B | 62.78B 394M 342M 320M 292M 549M 37.6B 558M 3.75B 1.47B 18.82B 1.48B 1.45B |
| Net Debt | -200B -1.26B -1.09B -1.02B -931M -1.75B -120B -1.78B -11.97B -4.69B -60.07B -4.72B -4.62B | -248B -1.56B -1.35B -1.26B -1.15B -2.17B -149B -2.21B -14.82B -5.81B -74.39B -5.85B -5.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | JP¥2,416.00 | -0.12% | 1,622,100 |
| 26-08-10 | JP¥2,419.00 | +1.62% | 1,335,600 |
| 26-08-07 | JP¥2,380.50 | +1.82% | 1,307,700 |
| 26-08-06 | JP¥2,338.00 | +1.61% | 1,513,200 |
| 26-08-05 | JP¥2,301.00 | -0.26% | 1,636,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
